CLINICAL_TRIALS
trial_result
· 2017-09-14
Clinical Trial Update: Nivolumab in Patients With Recurrent Malignant Mesothelioma [Phase 2]
Summary
Phase 2 clinical trial update for nivolumab in recurrent malignant pleural mesothelioma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The Netherlands Cancer Institute | Conditions: Malignant Pleural Mesothelioma | Phase 2 | Status: COMPLETED